StableEyes With Active Neurofeedback

Description

The investigators have developed a self-administered rehabilitation tool that incrementally guides the user to increase head motion to mitigate motion sickness and enhance postural recovery following centrifugation or unilateral vestibular nerve deafferentation surgery.

Conditions

Vestibular Disorder, Vestibular Schwannoma, Space Motion Sickness, Motion Sickness

Talk to us

Study Overview

On this page

Study Details

Study overview

The investigators have developed a self-administered rehabilitation tool that incrementally guides the user to increase head motion to mitigate motion sickness and enhance postural recovery following centrifugation or unilateral vestibular nerve deafferentation surgery.

StableEyes With Active Neurophysiological Feedback

StableEyes With Active Neurofeedback

Condition
Vestibular Disorder
Intervention / Treatment

-

Contacts and Locations

Baltimore

Johns Hopkins University, Baltimore, Maryland, United States, 21287

Dayton

Naval Medical Research Unit, Dayton, Ohio, United States, 45402

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Provision of signed and dated informed consent form
  • 2. Stated willingness to comply with all study procedures and availability for the duration of the study
  • 3. In good general health as evidenced by medical history or diagnosed with unilateral vestibular schwannoma
  • 4. Willing to adhere to the SWAN and/or vestibular rehabilitation regimen
  • 1. Current use of anti-nausea medication
  • 2. Presence of cervical spine pathology that limits head motion to \< 30 degrees in the horizontal or vertical plane (i.e. degenerative disc disease, rheumatoid arthritis)
  • 3. Any orthopedic pathology that prevents walking or standing independently (i.e. recent surgery)
  • 4. Legal blindness (20/200 or worse visual acuity)
  • 5. Treatment using a motion sickness investigational drug or other motion sickness behavioral intervention within 30 days

Ages Eligible for Study

21 Years to 70 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Johns Hopkins University,

Matthew Stewart, MD PhD, PRINCIPAL_INVESTIGATOR, Johns Hopkins University

Study Record Dates

2025-09-30